{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:20:44Z","timestamp":1790385644807,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T00:00:00Z","timestamp":1506470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T00:00:00Z","timestamp":1506470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Asociaci\u00f3n de Reumat\u00f3logos del Hospital de Cruces","award":["01\/2014"],"award-info":[{"award-number":["01\/2014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40744-017-0082-2","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T11:48:16Z","timestamp":1506512896000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort"],"prefix":"10.1007","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5268-1894","authenticated-orcid":false,"given":"Fernando","family":"Perez-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,27]]},"reference":[{"issue":"9711","key":"82_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette P, Bardin T. Gout. Lancet. 2010;375(9711):318\u201328.","journal-title":"Lancet"},{"key":"82_CR2","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout Part II. Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"82_CR3","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","volume":"340","author":"MM Wolfe","year":"1999","unstructured":"Wolfe MM, Licchtesntein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340(24):1888\u201399.","journal-title":"N Engl J Med"},{"issue":"3","key":"82_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1053\/j.ajkd.2004.12.005","volume":"45","author":"C Huerta","year":"2005","unstructured":"Huerta C, Castellsague J, VAras-Lorenzo C, Garcia-Rodriguez LA. Nonsteroidal anti-inflammatory drugs and the risk of ARF in the general population. Am J Kidney Dis. 2005;45(3):531\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"82_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/11531250-000000000-00000","volume":"27","author":"N Pratt","year":"2010","unstructured":"Pratt N, Roughead EE, Ryan P, Gilbert AL. Different impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations. Drugs Aging. 2010;27(1):63\u201371.","journal-title":"Drugs Aging"},{"key":"82_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker286","author":"KW Moon","year":"2011","unstructured":"Moon KW, Kim J, Kim JH, et al. Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemia. Rheumatol (Oxford). 2011. doi:10.1093\/rheumatology\/ker286.","journal-title":"Rheumatol (Oxford)"},{"key":"82_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, The ADQI Workgroup. Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Criti Care. 2004;8:204\u201312.","journal-title":"Criti Care"},{"key":"82_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201687","author":"M Doherty","year":"2012","unstructured":"Doherty M, Jansen TL, Nuki G, et al. Gout: why is this \u201ccurable\u201d disease so seldom cured? Ann Rheum Dis. 2012. doi:10.1136\/annrheumdis-2012-201687.","journal-title":"Ann Rheum Dis"},{"key":"82_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2007","unstructured":"Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005. Ann Rheum Dis. 2007;67:960\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"82_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/RHU.0b013e3182314d40","volume":"17","author":"F Perez-Ruiz","year":"2011","unstructured":"Perez-Ruiz F, Carmona L, Yebenes MJ, et al. An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study. J Clin Rheumatol. 2011;17(7):349\u201355.","journal-title":"J Clin Rheumatol"},{"issue":"7","key":"82_CR11","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.23007","volume":"57","author":"F Perez-Ruiz","year":"2007","unstructured":"Perez-Ruiz F, Liot\u00e9 F. Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout? Arthritis Rheum. 2007;57(7):1324\u20138.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"82_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/art.1780160402","volume":"16","author":"AB Gutman","year":"1973","unstructured":"Gutman AB. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum. 1973;16(4):431\u201345.","journal-title":"Arthritis Rheum"},{"key":"82_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000045783","volume":"86","author":"F Perez-Ruiz","year":"2000","unstructured":"Perez-Ruiz F, Calabozo M, Herrero-Beites AM, Garcia-Erauskin G, Pijoan JI. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron. 2000;86:287\u201391.","journal-title":"Nephron"},{"key":"82_CR14","first-page":"908","volume":"22","author":"M Bosi-Ferraz","year":"1995","unstructured":"Bosi-Ferraz M, O\u2019Brien B. A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis. J Rheumatol. 1995;22:908\u201314.","journal-title":"J Rheumatol"},{"issue":"4","key":"82_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/rheumatology\/keq346","volume":"50","author":"PP Khanna","year":"2011","unstructured":"Khanna PP, Perez-Ruiz F, Maranian P, Khanna D. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. Rheumatol (Oxford). 2011;50(4):740\u20135.","journal-title":"Rheumatol (Oxford)"},{"issue":"10","key":"82_CR16","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"Dinesh Khanna","year":"2012","unstructured":"Khanna D, FitzGerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part I: systematic non-pharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthitis Rheum (Hoboken). 2012;64(10):1431\u201346.","journal-title":"Arthritis Care & Research"},{"issue":"14","key":"82_CR17","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.clinthera.2011.01.008","volume":"32","author":"RL Wortmann","year":"2011","unstructured":"Wortmann RL, MacDonald PA, Hunt B, Jackson RL. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials. Clin Ther. 2011;32(14):2386\u201397.","journal-title":"Clin Ther"},{"key":"82_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.ejheart.2004.10.005","volume":"7","author":"T Juhlin","year":"2005","unstructured":"Juhlin T, Bj\u00f6rkman S, H\u00f6glund P. Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors. Eur J Heart Fail. 2005;7:1049\u201356.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"82_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11096-012-9631-5","volume":"34","author":"P Nygard","year":"2012","unstructured":"Nygard P, Jansman FG, Kruik-Kolloffel WJ, Barnaart AF, Brouwers JR. Effects of short-term addition of NSAID to diuretics and\/or RAAS-inhibitors on blood pressure and renal function. Int J Clin Pharm. 2012;34(3):468\u201374.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"82_CR20","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3899\/jrheum.110916","volume":"39","author":"HR Schumacher","year":"2012","unstructured":"Schumacher HR, Berger MF, Li-Yu J, Perez-Ruiz F, Burgos-Vargas R, Li C. Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial. J Rheumatol. 2012;39(9):1859\u201366.","journal-title":"J Rheumatol"},{"issue":"12","key":"82_CR21","first-page":"1461","volume":"15","author":"M Musu","year":"2011","unstructured":"Musu M, Finco G, Antonucci R, et al. Acute nephrotoxicity of NSAID from the foetus to the adult. Eur Rev med Pharmacol Sci. 2011;15(12):1461\u201372.","journal-title":"Eur Rev med Pharmacol Sci"},{"issue":"8","key":"82_CR22","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2215\/CJN.11451210","volume":"6","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Huddam B, Azak A, et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6(8):1887\u201394.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"82_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07435800.2011.566235","volume":"37","author":"G Melendez-Ramirez","year":"2012","unstructured":"Melendez-Ramirez G, Perez-Mendez O, Lopez-Osorio C, Kuri-Alfaro J, Espinola-Zavaleta N. Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia. Endocr Res. 2012;37(1):1\u20136.","journal-title":"Endocr Res"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-017-0082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-017-0082-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-017-0082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:09:55Z","timestamp":1724458195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-017-0082-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,27]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s40744-017-0082-2","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,27]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}